Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.

Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays Pfizer (Tag) Articles ...

XELJANZ® (tofacitinib citrate) receives marketing authorisation in the European Union for the treatment of moderate to severe active rheumatoid arthritis
http://www.worldpharmanews.com, , 27-Mar-2017
FDA warns Pfizer over contaminated drugs putting patients at risk
Bing Pharma News, naturalhealth365.com, 27-Mar-2017
FDA warns Pfizer over contaminated drugs putting patients at risk
Improving patients' pain experience in a large rural hospital.
Medline, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [74] 528-533, 27-Mar-2017
Treatment With Crizotinib Single Patient Expanded Access IND 134375
ClinicalTrials.gov, , 27-Mar-2017
A Phase II Trial to Evaluate Crizotinib in the Neoadjuvant Setting in Patients With Surgically Resectable, ALK, ROS1, or MET-oncogene Positive Non-small Cell Lung Cancer
ClinicalTrials.gov, , 27-Mar-2017
Temporary Authorization for Use (ATU) to Avelumab for Treatment of Adult Patients With Metastatic Merkel Cell Carcinoma (mMCC)
ClinicalTrials.gov, , 27-Mar-2017
A Phase 3, Placebo-controlled, Randomized, Observer-blinded Study To Evaluate The Efficacy, Safety, And Tolerability Of A Clostridium Difficile Vaccine In Adults 50 Years Of Age And Older
ClinicalTrials.gov, , 27-Mar-2017
Merck KGaA, Pfizer PD-L1 mAb Wins Accelerated Approval for Rare Skin Cancer
Bing Pharma News, Genetic Engineering & Biotechnology News [genengnews.com], 26-Mar-2017
US FDA approves Merck KGaA and Pfizer drug for rare skin cancer
Bing Pharma News, Domain-b [domain-b.com], 25-Mar-2017
Pfizer’s Immunotherapy for Skin Cancer Gets FDA Approval
Bing Pharma News, mrtopstep.com, 25-Mar-2017
Motley Fool: Add Pfizer, Bristol-Myers Squibb, and J&J to Your 401(k)
Bing Pharma News, News Max [newsmax.com], 25-Mar-2017
Motley Fool: Add Pfizer, Bristol-Myers Squibb, and J&J to Your 401(k)
Merck KGaA And Pfizer Get FDA Approval Of Checkpoint Inhibitor Avelumab For Rare Merkel Cell Skin Cancer Therapy
Bing Pharma News, talkmarkets.com, 25-Mar-2017
Confirmation of longer FIX activity half-life with prolonged sample collection after single doses of nonacog alfa in patients with haemophilia B.
Medline, Thrombosis and haemostasis, 25-Mar-2017

  This Weeks Pfizer (Tag) Articles ...

Merck, Pfizer get FDA nod for Bavencio to treat metastatic Merkel cell carcinoma
Bing Pharma News, PBR Regulatory Affairs [regulatoryaffairs.pharmaceutical-business-review.com], 24-Mar-2017
FDA Grants Approval for Bavencio
Bing Pharma News, Phramalive.com, 24-Mar-2017
Merck KGaA top DAX performer on FDA drug approval
Bing Pharma News, Times of India [timesofindia.indiatimes.com], 24-Mar-2017
FDA Approves Drug for Rare Skin Cancer
Bing Pharma News, mundoaguaysaneamiento.net, 24-Mar-2017
FDA Grants Approval for avelumab
Bing Pharma News, Bonity.com, 24-Mar-2017
Showing Records 0 ... 20  

The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts


Name: Pfizer (Tag)
Type: Company



Must Mention A:

In Context:


Show Most Frequent

Optional, Only Include Source:


[Not available (Why?)]